Myomo (MYO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
MYO slides 7.7% to $1.20, a 1-month low. Closed at $1.20, -7.69% vs the prior close of $1.30. Day range $1.20β$1.33, opened at $1.32.
MYO daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β MYO slides 7.7% to $1.20, a 1-month low
- Closed at $1.20, -7.69% vs the prior close of $1.30. Day range $1.20β$1.33, opened at $1.32.
- Volume was 337.79K shares, 0.6x its 50-day average of 534.34K.
- Price is -19.4% vs its 50-day average ($1.49) and +12.6% vs its 200-day average ($1.07).
- 52-week range $0.61β$1.88; today's close sits at 46% of that range, 36.3% below the 52-week high.
Oct 15, 2026 β MYO jumps 4.8% to $1.30
- Closed at $1.30, +4.84% vs the prior close of $1.24. Day range $1.21β$1.31, opened at $1.24.
- Volume was 215.10K shares, 0.4x its 50-day average of 541.26K β lighter than usual.
- Price is -12.8% vs its 50-day average ($1.49) and +22.1% vs its 200-day average ($1.06).
- 52-week range $0.61β$1.88; today's close sits at 54% of that range, 31.0% below the 52-week high.
Oct 14, 2026 β MYO slides 3.9% to $1.24, 3 down days in a row
- Closed at $1.24, -3.88% vs the prior close of $1.29. Day range $1.24β$1.33, opened at $1.27.
- Volume was 442.70K shares, 0.8x its 50-day average of 538.64K.
- Price is -16.5% vs its 50-day average ($1.49) and +16.7% vs its 200-day average ($1.06).
- 52-week range $0.61β$1.88; today's close sits at 50% of that range, 34.2% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 β MYO slides 5.1% to $1.29
- Closed at $1.29, -5.15% vs the prior close of $1.36. Day range $1.27β$1.41, opened at $1.39.
- Volume was 341.90K shares, 0.6x its 50-day average of 537.84K.
- Price is -13.0% vs its 50-day average ($1.48) and +21.5% vs its 200-day average ($1.06).
- 52-week range $0.61β$1.88; today's close sits at 54% of that range, 31.6% below the 52-week high.
Oct 12, 2026 β MYO slides 4.9% to $1.36
- Closed at $1.36, -4.90% vs the prior close of $1.43. Day range $1.34β$1.45, opened at $1.45.
- Volume was 159.80K shares, 0.3x its 50-day average of 541.25K β lighter than usual.
- Price is -7.9% vs its 50-day average ($1.48) and +28.3% vs its 200-day average ($1.06).
- 52-week range $0.61β$1.88; today's close sits at 59% of that range, 27.9% below the 52-week high.
Oct 9, 2026 β MYO rises 1.4% to $1.43
- Closed at $1.43, +1.42% vs the prior close of $1.41. Day range $1.41β$1.45, opened at $1.42.
- Volume was 101.60K shares, 0.2x its 50-day average of 546.48K β lighter than usual.
- Price is -2.7% vs its 50-day average ($1.47) and +35.2% vs its 200-day average ($1.06).
- 52-week range $0.61β$1.88; today's close sits at 64% of that range, 24.1% below the 52-week high.
Oct 8, 2026 β MYO dips 2.8% to $1.41, 3 down days in a row
- Closed at $1.41, -2.76% vs the prior close of $1.45. Day range $1.38β$1.47, opened at $1.43.
- Volume was 232.10K shares, 0.4x its 50-day average of 548.30K β lighter than usual.
- Price is -3.5% vs its 50-day average ($1.46) and +33.6% vs its 200-day average ($1.06).
- 52-week range $0.61β$1.88; today's close sits at 63% of that range, 25.2% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 β MYO slides 9.9% to $1.45
- Closed at $1.45, -9.94% vs the prior close of $1.61. Day range $1.40β$1.59, opened at $1.57.
- Volume was 454.80K shares, 0.8x its 50-day average of 544.61K.
- Price is -0.1% vs its 50-day average ($1.45) and +37.7% vs its 200-day average ($1.05).
- 52-week range $0.61β$1.88; today's close sits at 66% of that range, 23.1% below the 52-week high.
Oct 6, 2026 β MYO slides 3.6% to $1.61
- Closed at $1.61, -3.59% vs the prior close of $1.67. Day range $1.59β$1.78, opened at $1.73.
- Volume was 331.80K shares, 0.6x its 50-day average of 541.33K.
- Price is +11.6% vs its 50-day average ($1.44) and +53.3% vs its 200-day average ($1.05).
- 52-week range $0.61β$1.88; today's close sits at 79% of that range, 14.6% below the 52-week high.
Oct 5, 2026 β MYO rises 2.5% to $1.67, 3 up days in a row
- Closed at $1.67, +2.45% vs the prior close of $1.63. Day range $1.60β$1.73, opened at $1.60.
- Volume was 272.90K shares, 0.5x its 50-day average of 541.12K β lighter than usual.
- Price is +16.7% vs its 50-day average ($1.43) and +59.5% vs its 200-day average ($1.05).
- 52-week range $0.61β$1.88; today's close sits at 83% of that range, 11.4% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 β MYO rises 1.2% to $1.63
- Closed at $1.63, +1.24% vs the prior close of $1.61. Day range $1.61β$1.70, opened at $1.64.
- Volume was 171.80K shares, 0.3x its 50-day average of 540.03K β lighter than usual.
- Price is +15.0% vs its 50-day average ($1.42) and +56.2% vs its 200-day average ($1.04).
- 52-week range $0.61β$1.88; today's close sits at 80% of that range, 13.5% below the 52-week high.
MYO latest news & SEC filings
Every SEC filing by or about MYO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Kovelman Harry received an award of 32,500 shares on Oct 13, 2026; now holds 122,389
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 15, 2026 Β· Form 4/A β Insider trade (amended)
Amended insider trade report (Form 4/A)
- Kovelman Harry sold 15,844 shares at $1.27 (β$20.14K) on Sep 11, 2026; now holds 89,889
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 15, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Henry David A received an award of 51,250 shares on Oct 13, 2026; now holds 549,862
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 15, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Gudonis Paul R received an award of 71,250 shares on Oct 13, 2026; now holds 1,514,292
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Henry David A received an award of 6,272 shares on Oct 9, 2026; now holds 501,745
- Henry David A had withheld for taxes 3,133 shares at $1.37 (β$4.29K) on Oct 12, 2026; now holds 498,612
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Gudonis Paul R received an award of 8,363 shares on Oct 9, 2026; now holds 1,443,042
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 12, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 5, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $11.70M (prior year $9.65M) (+21.3% vs Jun 30, 2025)
- Net income: -$4.02M (prior year -$4.63M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.09 (prior year -$0.11) (loss narrowed vs Jun 30, 2025)
Aug 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 29, 2026 Β· Form 8-K/A β Current report (amended)
Amended current report
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
- Item 5.03 β Amended its charter or bylaws / changed fiscal year.
- Item 5.07 β Reported shareholder vote results.
Jun 26, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
- Item 5.03 β Amended its charter or bylaws / changed fiscal year.
- Item 5.07 β Reported shareholder vote results.
Things to know before you trade MYO
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 9, 2026, Nov 10, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.57% (largest 9.9%). That is a volatile stock.
- Liquidity: about 294.51K shares (β$353.41K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.20 vs a range of $0.61β$1.88 (46% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 5 open-market buys, 20 sales; latest: Harry Kovelman sold 15,488 shares on Sep 11, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K Jun 26, 2026.
- Share count: 39.61M shares outstanding (Jul 31, 2026), +4.8% vs a year earlier.
- Listing: NYSE Β· industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
MYO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.32 | 1.33 | 1.20 | 1.20 | 337.79K |
| Oct 15, 2026 | 1.24 | 1.31 | 1.21 | 1.30 | 215.10K |
| Oct 14, 2026 | 1.27 | 1.33 | 1.24 | 1.24 | 442.70K |
| Oct 13, 2026 | 1.39 | 1.41 | 1.27 | 1.29 | 341.90K |
| Oct 12, 2026 | 1.45 | 1.45 | 1.34 | 1.36 | 159.80K |
| Oct 9, 2026 | 1.42 | 1.45 | 1.41 | 1.43 | 101.60K |
| Oct 8, 2026 | 1.43 | 1.47 | 1.38 | 1.41 | 232.10K |
| Oct 7, 2026 | 1.57 | 1.59 | 1.40 | 1.45 | 454.80K |
| Oct 6, 2026 | 1.73 | 1.78 | 1.59 | 1.61 | 331.80K |
| Oct 5, 2026 | 1.60 | 1.73 | 1.60 | 1.67 | 272.90K |
| Oct 2, 2026 | 1.64 | 1.70 | 1.61 | 1.63 | 171.80K |
| Oct 1, 2026 | 1.54 | 1.65 | 1.51 | 1.61 | 305.60K |
| Sep 30, 2026 | 1.61 | 1.63 | 1.49 | 1.56 | 368.10K |
| Sep 29, 2026 | 1.58 | 1.61 | 1.54 | 1.57 | 133.70K |
| Sep 28, 2026 | 1.57 | 1.67 | 1.56 | 1.56 | 278.10K |
| Sep 25, 2026 | 1.66 | 1.70 | 1.60 | 1.61 | 219.70K |
| Sep 24, 2026 | 1.63 | 1.67 | 1.59 | 1.67 | 272.40K |
| Sep 23, 2026 | 1.65 | 1.68 | 1.58 | 1.64 | 294.00K |
| Sep 22, 2026 | 1.55 | 1.71 | 1.53 | 1.64 | 603.60K |
| Sep 21, 2026 | 1.51 | 1.58 | 1.47 | 1.57 | 352.70K |
About Myomo
Myomo (MYO) is listed on the NYSE and classified by the SEC under βOrthopedic, Prosthetic & Surgical Appliances & Suppliesβ. Its business address is in BOSTON, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1369290.
MYO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Thomas Aloysius Jr. Crowley | Director | Jun 26, 2026 |
| William J Febbo | Director | Jun 26, 2026 |
| Paul R Gudonis | Chief Executive Officer | Aug 11, 2026 |
| Heather C Getz | Director | Jun 26, 2026 |
| Thomas F Kirk | Director | Jun 26, 2026 |
| Joseph M. Jr. Manko | Director | Jun 26, 2026 |
| Milton Mayo Morris | Director | Sep 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Paul R Gudonis | Chief Executive Officer | Aug 11, 2026 |
| David A Henry | Chief Financial Officer | Aug 11, 2026 |
| Harry Kovelman | Chief Medical Officer | Sep 14, 2026 |
| Micah Mitchell | Chief Commercial Officer | Aug 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Harry Kovelman | Sale | 15,488 | $1.27 |
| Sep 11, 2026 | Harry Kovelman | Sale | 15,488 | $1.27 |
| Sep 11, 2026 | Harry Kovelman | Sale | 15,488 | $1.27 |
| Sep 11, 2026 | Harry Kovelman | Sale | 15,488 | $1.27 |
| Sep 2, 2026 | Milton Mayo Morris | Sale | 15,000 | $1.41 |
| Sep 2, 2026 | Milton Mayo Morris | Sale | 15,000 | $1.41 |
| Sep 2, 2026 | Milton Mayo Morris | Sale | 15,000 | $1.41 |
| Sep 2, 2026 | Milton Mayo Morris | Sale | 15,000 | $1.41 |
| Aug 20, 2026 | Harry Kovelman | Sale | 17,500 | $1.73 |
| Aug 20, 2026 | Harry Kovelman | Sale | 17,500 | $1.73 |
| Aug 20, 2026 | Harry Kovelman | Sale | 17,500 | $1.73 |
| Aug 20, 2026 | Harry Kovelman | Sale | 17,500 | $1.73 |
| Aug 20, 2026 | Harry Kovelman | Sale | 17,250 | $1.73 |
| Aug 20, 2026 | Harry Kovelman | Sale | 17,250 | $1.73 |
| Aug 20, 2026 | Harry Kovelman | Sale | 17,250 | $1.73 |
MYO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $40.93M | $-15.57M | -0.37 | $-14.51M |
| Dec 31, 2024 | $32.55M | $-6.18M | -0.16 | $-3.29M |
| Dec 31, 2023 | $19.24M | $-8.15M | -0.28 | $-6.17M |
| Dec 31, 2022 | $15.56M | $-10.72M | -1.52 | $-10.23M |
| Dec 31, 2021 | $13.86M | $-10.37M | -1.89 | $-9.55M |
Latest balance sheet: total assets $35.34M, total liabilities $29.51M, cash $11.22M (as of Jun 30, 2026).
MYO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $1.06 |
| May 7, 2026 | 8-K Item 2.02 (results) | $0.87 |
| Mar 9, 2026 | 8-K Item 2.02 (results) | $0.81 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $0.92 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $1.76 |
| May 7, 2025 | 8-K Item 2.02 (results) | $4.84 |
| Mar 10, 2025 | 8-K Item 2.02 (results) | $4.17 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $4.18 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | β |
| Jul 8, 2024 | 8-K Item 2.02 (results) | β |
| May 8, 2024 | 8-K Item 2.02 (results) | β |
| Mar 7, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· Orthopedic, Prosthetic & Surgical Appliances & Supplies
Intuitive Surgical (ISRG)Edwards Lifesciences (EW)Zimmer Biomet (ZBH)Align Technology (ALGN)Steris (STE)MSA Safety (MSA)Smith & Nephew (SNN)Enovis (ENOV)Establishment Labs (ESTA)Cadre (CDRE)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MYO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.